Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
ClinicalTrials.gov ID NCT06948955
Sponsor Cogent Biosciences, Inc.
Information provided by Cogent Biosciences, Inc. (Responsible Party)
Trial Information: https://clinicaltrials.gov/study/NCT06948955